The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Lopac-S-3442     3-(2,4-dichlorophenyl)-4-(1- methylindol-3...

Synonyms: Tocris-1616, SureCN30251, S1075_Selleck, CHEMBL102714, cc-383, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Lopac-S-3442

  • Rats were treated with vehicle, morphine (300 microg/kg), the delta-opioid agonist fentanyl isothiocynate (FIT, 10 microg/kg), or the GSK inhibitor SB-216763 (SB21, 600 microg/kg) 10 min before ischemia [1].

High impact information on Lopac-S-3442


Biological context of Lopac-S-3442

  • However, the selective glycogen synthase kinase-3beta inhibitors SB-415286 and SB-216763 were unable to prevent colchicine-induced apoptosis in these cells, suggesting that the anti-apoptotic activity of lithium is not mediated by glycogen synthase kinase-3beta under these conditions [7].

Gene context of Lopac-S-3442


  1. The JAK/STAT pathway is essential for opioid-induced cardioprotection: JAK2 as a mediator of STAT3, Akt, and GSK-3 beta. Gross, E.R., Hsu, A.K., Gross, G.J. Am. J. Physiol. Heart Circ. Physiol. (2006) [Pubmed]
  2. An inactive pool of GSK-3 at the leading edge of growth cones is implicated in Semaphorin 3A signaling. Eickholt, B.J., Walsh, F.S., Doherty, P. J. Cell Biol. (2002) [Pubmed]
  3. Activation of the Wnt signaling pathway in chronic lymphocytic leukemia. Lu, D., Zhao, Y., Tawatao, R., Cottam, H.B., Sen, M., Leoni, L.M., Kipps, T.J., Corr, M., Carson, D.A. Proc. Natl. Acad. Sci. U.S.A. (2004) [Pubmed]
  4. Glycogen synthase kinase-3 is a negative regulator of extracellular signal-regulated kinase. Wang, Q., Zhou, Y., Wang, X., Evers, B.M. Oncogene (2006) [Pubmed]
  5. Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Coghlan, M.P., Culbert, A.A., Cross, D.A., Corcoran, S.L., Yates, J.W., Pearce, N.J., Rausch, O.L., Murphy, G.J., Carter, P.S., Roxbee Cox, L., Mills, D., Brown, M.J., Haigh, D., Ward, R.W., Smith, D.G., Murray, K.J., Reith, A.D., Holder, J.C. Chem. Biol. (2000) [Pubmed]
  6. Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death. Cross, D.A., Culbert, A.A., Chalmers, K.A., Facci, L., Skaper, S.D., Reith, A.D. J. Neurochem. (2001) [Pubmed]
  7. Implication of cyclin-dependent kinase 5 in the neuroprotective properties of lithium. Jordà, E.G., Verdaguer, E., Canudas, A.M., Jiménez, A., Garcia de Arriba, S., Allgaier, C., Pallàs, M., Camins, A. Neuroscience (2005) [Pubmed]
  8. Erythropoietin affords additional cardioprotection to preconditioned hearts by enhanced phosphorylation of glycogen synthase kinase-3 beta. Nishihara, M., Miura, T., Miki, T., Sakamoto, J., Tanno, M., Kobayashi, H., Ikeda, Y., Ohori, K., Takahashi, A., Shimamoto, K. Am. J. Physiol. Heart Circ. Physiol. (2006) [Pubmed]
  9. GSK-3 inhibition by adenoviral FRAT1 overexpression is neuroprotective and induces Tau dephosphorylation and beta-catenin stabilisation without elevation of glycogen synthase activity. Culbert, A.A., Brown, M.J., Frame, S., Hagen, T., Cross, D.A., Bax, B., Reith, A.D. FEBS Lett. (2001) [Pubmed]
WikiGenes - Universities